Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


UCL Launches Newly Redesigned iTunes U Site

24 September 2010

UCL on iTunes U has a new layout which makes content easier to search and displays relevant content to users. Read more...